Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Tuesday, November 19, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Tessl Secures $125M for AI Software Development
Bio-Techne & ALZpath Partner to Advance Neurodegenerative Research
Optilogic Unveils Leapfrog AI to Transform Supply Chain Design
NVIDIA Unveils Omniverse Real-Time Physics with Industry Partners
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
SCHIZOPHRENIA
SCHIZOPHRENIA
Healthcare
Maplight Therapeutics Announces Initiation of Phase 1 Clinical Trial for Novel Therapy
PR Newswire
-
February 7, 2022
MapLight Therapeutics announced it has initiated a Phase 1 clinical trial evaluating ML-007, a novel therapeutic developed to target circuits understood to be dysfunctional...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Tessl Secures $125M for AI Software Development
Bio-Techne & ALZpath Partner to Advance Neurodegenerative Research
Optilogic Unveils Leapfrog AI to Transform Supply Chain Design
Load more
